Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caudal Dexmedetomidine for Sevoflurane Induced Emergence Agitation in Children
NCT02757495Phase 4Completed
- Sponsor
- Suez Canal University
- Start
- Apr 2016
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in Emergence agitation (EA) (2 arms), sponsored by Suez Canal University. Primary endpoint: Degree of Emergence Agitation. Started Apr 2016; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on NCT02757495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02757495.